Solventum Corporation (NYSE:SOLV) is included in our list of the 12 Cheap Value Stocks to Buy Now According to Seth Klarman.
A closeup shot of a laboratory technician handling a medical device used for fertility treatments.
On August 7, 2025, Solventum Corporation (NYSE:SOLV) announced its results for Q2 2025. The quarter marked the fifth consecutive quarter of positive volume growth, with the company recording sales of $2.2 billion, up 3.9% YoY (2.8% organic). This helped Solventum deliver an adjusted EPS of $1.69, beating expectations, along with an operating cash flow of $169 million.
Looking ahead, Solventum Corporation raised its 2025 guidance, expecting organic sales growth of 2.0%-3.0% and adjusted EPS of $5.80-$5.95, thanks to strong performance across all segments during the quarter. Following the strong quarterly performance and raised full-year guidance, on August 8, 2025, Piper Sandler raised its price target on the company from $87 to $94, maintaining an ‘Overweight’ rating. The analyst cited Solventum’s consistent execution. Meanwhile, on the same day, Wells Fargo maintained its ‘Hold’ rating with a $79 target.
Ahead of the planned sale of its Purification & Filtration segment and retention of the Drinking Water Filtration segment, Solventum Corporation confirmed its free cash flow guidance of $450-$550 million for 2025.
Solventum Corporation is a global leader in innovative medical technology and solutions. It is included in our list of cheap value stocks to buy.
READ NEXT: 13 Best Oil Refinery Stocks to Buy Right Now and 7 Best Potash Stocks to Buy According to Analysts.
